The exemption may be short-lived if President Trump makes good on threats to use tariffs as leverage to bring drug production ...

President Trump has long bemoaned a lack of domestic pharmaceutical production and has repeatedly promised tariffs to bring ...

X4 Pharmaceuticals, Inc. (XFOR) on Tuesday reported a loss of $39.8 million in its fourth quarter. On a per-share basis, the Boston-based company said it had a loss of ...

Jazz Pharmaceuticals, a Zacks Rank #1 (Strong Buy), is a specialty biopharmaceutical company that identifies, develops, and commercializes pharmaceutical products in the United States, Europe ...